116 related articles for article (PubMed ID: 7639472)
1. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental study.
Mattsson C; Magnuson K; Hellström S
Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):625-32. PubMed ID: 7639472
[TBL] [Abstract][Full Text] [Related]
2. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin e treatment.
Polat S; Oztürk O; Uneri C; Yüksel M; Haklar G; Bozkurt S; Küllü S
Laryngoscope; 2004 Apr; 114(4):720-5. PubMed ID: 15064630
[TBL] [Abstract][Full Text] [Related]
3. Tympanometric changes in an experimental myringosclerosis model after myringotomy.
Kazikdas KC; Serbetcioglu B; Boyraz I; Tugyan K; Erbil G; Yilmaz O; Onal K
Otol Neurotol; 2006 Apr; 27(3):303-7. PubMed ID: 16639266
[TBL] [Abstract][Full Text] [Related]
4. The anti-oxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis.
Kazikdas KC; Uguz MZ; Erbil G; Tugyan K; Yilmaz O; Guneli E; Altun Z
Otol Neurotol; 2006 Sep; 27(6):882-6. PubMed ID: 16788415
[TBL] [Abstract][Full Text] [Related]
5. Myringotomy: a prerequisite for the development of myringosclerosis?
Mattsson C; Magnuson K; Hellström S
Laryngoscope; 1998 Jan; 108(1 Pt 1):102-6. PubMed ID: 9432076
[TBL] [Abstract][Full Text] [Related]
6. Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy.
Mattsson C; Stierna P; Hellström S
Am J Otol; 2000 Nov; 21(6):804-8. PubMed ID: 11078067
[TBL] [Abstract][Full Text] [Related]
7. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis.
Mattsson C; Marklund SL; Hellström S
Ann Otol Rhinol Laryngol; 1997 Jun; 106(6):513-8. PubMed ID: 9199613
[TBL] [Abstract][Full Text] [Related]
8. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat.
Spratley JE; Hellström SO; Mattsson CK; Pais-Clemente M
Ann Otol Rhinol Laryngol; 2001 Jun; 110(6):585-91. PubMed ID: 11407852
[TBL] [Abstract][Full Text] [Related]
9. The anti-oxidant and anti-apoptotic activities of selenium in the prevention of myringosclerosis in rats.
Görür K; Ozcan C; Polat A; Unal M; Tamer L; Cinel I
J Laryngol Otol; 2002 Jun; 116(6):426-9. PubMed ID: 12385352
[TBL] [Abstract][Full Text] [Related]
10. The preventive effect of N-nitro L-arginine methyl ester in experimentally induced myringosclerosis.
Dogan E; Erdag TK; Sarioglu S; Ecevit MC; Ikiz AO; Güneri EA
Int J Pediatr Otorhinolaryngol; 2011 Aug; 75(8):1035-9. PubMed ID: 21669465
[TBL] [Abstract][Full Text] [Related]
11. The effect of intraperitoneal administration of zinc aspartate on myringosclerosis in perforated tympanic membranes of rats.
Yildirim I; Ciralik H; Okur E; Aydoğan B; Kiliç MA
Kulak Burun Bogaz Ihtis Derg; 2009; 19(5):263-7. PubMed ID: 19961406
[TBL] [Abstract][Full Text] [Related]
12. The impact of topical and systemic enoxaparin sodium use on traumatic tympanic membrane perforation and myringosclerosis.
Bilge A; Gunes A; Dagli M; Koybasioglu FF; Guvey A
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3035-41. PubMed ID: 26796878
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane.
Ozcan C; Görür K; Cinel L; Talas DU; Unal M; Cinel I
Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):179-84. PubMed ID: 11997152
[TBL] [Abstract][Full Text] [Related]
14. Myringotomized tympanic membranes cultured in vitro do not develop myringosclerosis.
Mattsson C; Berggren D; Hellström S
Acta Otolaryngol; 2002 Mar; 122(2):168-72. PubMed ID: 11936908
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical mitomycin and trimetazidine on myringosclerosis.
Cankaya H; Kösem M; Kiroglu F; Kiris M; Yuca K; Oztürk G; Dülger H; Erdogan E
J Otolaryngol Head Neck Surg; 2008 Dec; 37(6):882-7. PubMed ID: 19128721
[TBL] [Abstract][Full Text] [Related]
16. The effect of local administration of N-acetylcysteine in perforated rat tympanic membrane: an experimental study in myringosclerosis.
Ozcan C; Polat G; Görür K; Talas DU; Bağdatoğlu O; Cinel I
Pharmacol Res; 2002 Jan; 45(1):5-9. PubMed ID: 11820854
[TBL] [Abstract][Full Text] [Related]
17. Levels of reactive oxygen species in rat tympanic membranes after incisional versus radiofrequency myringotomy.
Sakalli E; Baylancicek S; Yuksel M; Erdurak SC; Dadas B
Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):792-5. PubMed ID: 23478016
[TBL] [Abstract][Full Text] [Related]
18. The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis.
Song JJ; Kwon SK; Cho CG; Park SW
Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1287-91. PubMed ID: 17544518
[TBL] [Abstract][Full Text] [Related]
19. Myringosclerosis develops within 9h of myringotomy.
Mattsson C; Johansson C; Hellström S
ORL J Otorhinolaryngol Relat Spec; 1999; 61(1):31-6. PubMed ID: 9892867
[TBL] [Abstract][Full Text] [Related]
20. Is there any effect of montelukast on prevention of myringosclerosis after myringotomy in a rat model?
Kargin Kaytez S; Kavuzlu A; Yumusak N; Oçal R; Akkoca O
Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):57-62. PubMed ID: 30377759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
